94.9 F
San Fernando
Saturday, Feb 24, 2024

IRIS Meets Guidance for Year

IRIS International Inc. met its guidance for its 2008 fiscal year on strong sales of its health care products. The Chatsworth-based in vitro diagnostics company reported a net income of $9 million, or $0.48 per diluted share, on revenues of $95.5 million. For the previous fiscal year the company reported a net income of $7.5 million, or $0.40 per diluted share, on revenues of $84.3 million. Guidance for the year was set at $94 million in revenues and earnings at $0.43 per diluted share. For the fourth quarter ending Dec. 31, IRIS reported a net income of $3.4 million, or $0.18 per diluted share, on revenues of $26.7 million. For the same period in the previous year, the company reported net income of $2.7 million, or $0.14 per diluted share, on revenues of $21.9 million. Nadra Kareem

Featured Articles

Related Articles